Incidence of non-cardia gastric cancer among commercially-insured individuals aged 18-64 with chronic atrophic gastritis

  • 0Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, United States of America.

|

|

Summary

This summary is machine-generated.

Individuals with chronic atrophic gastritis (CAG) have an increased risk of developing non-cardia gastric cancer (NCGC). Key risk factors include age over 50, anemia, smoking, and family history.

Area Of Science

  • Gastroenterology
  • Oncology
  • Epidemiology

Background

  • Chronic atrophic gastritis (CAG) is a precancerous condition of the gastric mucosa.
  • CAG predisposes individuals to non-cardia gastric cancer (NCGC).
  • The risk of NCGC after CAG diagnosis in the U.S. requires robust description.

Purpose Of The Study

  • To estimate the risk of NCGC following CAG diagnosis in a U.S. population.
  • To identify individual-level risk factors associated with NCGC development in patients with CAG.

Main Methods

  • Utilized a large commercial claims database (Marketscan) of privately-insured Americans aged 18-64.
  • Created a cohort of individuals diagnosed with CAG and followed them for NCGC development.
  • Captured demographic and clinical data, linking to socioeconomic status measures.

Main Results

  • Analyzed data from 107,835 individuals with 355,591 person-years of follow-up.
  • Observed an overall crude NCGC incidence of 98 per 100,000 person-years.
  • Identified age ≥50, anemia, smoking, and family history as significant risk factors for NCGC.

Conclusions

  • This study provides early estimates of NCGC risk post-CAG diagnosis in the U.S.
  • Identified key risk factors that can inform targeted prevention strategies.
  • Findings may guide future endoscopic surveillance protocols in the United States.

Related Concept Videos

Gastritis-I: Introduction and Types 01:27

1.0K

Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...

Gastritis-II: Pathophysiology 01:17

601

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

Gastritis III: Clinical Manifestations and Management 01:23

500

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...

Barrett Esophagus-I: Introduction 01:21

224

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...

Peptic Ulcer Disease I: Introduction 01:30

302

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies 01:28

209

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.

Location of Pain:...